Stock Chart
REPL
Type: SELL wallstreet
Strike: $12
Premium: $3.55
Expiry: Jan 15, 2027
Target: $13
Score: -76
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About REPL - Replimune Group, Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its …
Key Statistics
More REPL Analysis
This REPL stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track REPL's price movements with trendlines, gamma walls, and key support/resistance levels.